LEO Pharma gets scientific approval of Enstilar to treat Psoriasis in EU
Enstilar is an alcohol-free foam formulation for the topical treatment for psoriasis vulgaris. LEO Pharma president and CEO Gitte Aabo said: "The scientific approval of Enstilar is exciting
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.